Endocrinology, Vol 116, 830-834, Copyright © 1985 by Endocrine Society

ARTICLES

Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity

F Rohner-Jeanrenaud and B Jeanrenaud

The etiology of the abnormal secretion of hormones from the endocrine pancreas of genetically obese (fa/fa) rats is unknown. In this study, we tested the postulate that there is an early occurrence of increased efferent parasympathetic activity to the endocrine pancreas of these rodents. Unweaned female 17-day-old pups were anesthetized and tested by an iv bolus of arginine to stimulate insulin and glucagon output. At the time of the tests, pups were indistinguishable from each other. They were, therefore, kept to adulthood to allow for their separation into an obese (25% of total animals) and a lean (75%) group. Those animals that became obese were retrospectively referred to as preobese. Basal insulinemia and glucagonemia were identical in the two groups, as were the dynamics of arginine-induced hormone release. However, arginine-induced insulin as well as glucagon output were higher in preobese than in lean pups. These two abnormalities were abolished by acute atropine pretreatment. It is concluded that the substrate-induced insulin and glucagon oversecretion of preobese pups is an early defect that is mediated via the vagus nerve.

This article has been cited by other articles:

				K. L. Teff and R. R. Townsend Prolonged Mild Hyperglycemia Induces Vagally Mediated Compensatory Increase in C-Peptide Secretion in Humans J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5606 - 5613. [Abstract] [Full Text] [PDF]

				A. Duttaroy, C. L. Zimliki, D. Gautam, Y. Cui, D. Mears, and J. Wess Muscarinic Stimulation of Pancreatic Insulin and Glucagon Release Is Abolished in M3 Muscarinic Acetylcholine Receptor-Deficient Mice Diabetes, July 1, 2004; 53(7): 1714 - 1720. [Abstract] [Full Text] [PDF]

				R. H. Lustig, S. R. Post, K. Srivannaboon, S. R. Rose, R. K. Danish, G. A. Burghen, X. Xiong, S. Wu, and T. E. Merchant Risk Factors for the Development of Obesity in Children Surviving Brain Tumors J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 611 - 616. [Abstract] [Full Text] [PDF]

				S. Kooptiwut, S. Zraika, A. W. Thorburn, M. E. Dunlop, R. Darwiche, T. W. Kay, J. Proietto, and S. Andrikopoulos Comparison of Insulin Secretory Function in Two Mouse Models with Different Susceptibility to {beta}-Cell Failure Endocrinology, June 1, 2002; 143(6): 2085 - 2092. [Abstract] [Full Text] [PDF]

				P. Gilon and J.-C. Henquin Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic {beta}-Cell Function Endocr. Rev., October 1, 2001; 22(5): 565 - 604. [Abstract] [Full Text] [PDF]

				K. L. Teff and R. R. Townsend Early phase insulin infusion and muscarinic blockade in obese and lean subjects Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R198 - R208. [Abstract] [Full Text] [PDF]

				K. L. Teff, A. Alavi, J. Chen, M. Pourdehnad, and R. R. Townsend Muscarinic blockade inhibits gastric emptying of mixed-nutrient meal: effects of weight and gender Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R707 - R714. [Abstract] [Full Text] [PDF]